Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical TrialAndrew Ahmann, Vanita R. Aroda, Matthew Capehorn et al.|Diabetes Care|2017Cited by 574
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 TrialHelena W. Rodbard, Е. О. Филиппова, Chaicharn Deerochanawong et al.|Diabetes Care|2019Cited by 442
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian PopulationSilvia Cantara, Furio Pacini, Tania Pilli et al.|The Journal of Clinical Endocrinology & Metabolism|2014Cited by 56
Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulationGiuseppina Emanuela Grieco, Francesco Dotta|Cell Death Discovery|2022Cited by 20
Reduced miR-184-3p expression occurring in Type 2 diabetic pancreatic islets protects β-cells from lipotoxic and proinflammatory apoptosis via a CRTC1-dependent mechanismGiuseppina Emanuela Grieco, Francesco Dotta|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 2